OPC-415
/ Otsuka, Osaka University
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
May 23, 2025
Safety and Efficacy Study of OPC-415 in Patients With Relapsed and/or Refractory Multiple Myeloma
(clinicaltrials.gov)
- P1/2 | N=11 | Active, not recruiting | Sponsor: Otsuka Pharmaceutical Co., Ltd. | Recruiting ➔ Active, not recruiting | N=49 ➔ 11 | Trial primary completion date: Jan 2027 ➔ Apr 2025
Enrollment change • Enrollment closed • Trial primary completion date • Hematological Malignancies • Multiple Myeloma • Oncology
1 to 1
Of
1
Go to page
1